These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

562 related items for PubMed ID: 32507961

  • 21. Treatment for IgA nephropathy with stage 3 or 4 chronic kidney disease: low-dose corticosteroids combined with oral cyclophosphamide.
    Ma F, Yang X, Zhou M, Bai M, Zhao L, Li L, Dong R, Liu C, Li R, Sun S.
    J Nephrol; 2020 Dec; 33(6):1241-1250. PubMed ID: 32447619
    [Abstract] [Full Text] [Related]

  • 22. Serum immunoglobulin A/C3 ratio predicts progression of immunoglobulin A nephropathy.
    Zhang J, Wang C, Tang Y, Peng H, Ye ZC, Li CC, Lou TQ.
    Nephrology (Carlton); 2013 Feb; 18(2):125-31. PubMed ID: 23134230
    [Abstract] [Full Text] [Related]

  • 23. Measures of Urinary Protein and Albumin in the Prediction of Progression of IgA Nephropathy.
    Zhao YF, Zhu L, Liu LJ, Shi SF, Lv JC, Zhang H.
    Clin J Am Soc Nephrol; 2016 Jun 06; 11(6):947-955. PubMed ID: 27026518
    [Abstract] [Full Text] [Related]

  • 24. IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences.
    Riispere Ž, Laurinavičius A, Kuudeberg A, Seppet E, Sepp K, Ilmoja M, Luman M, Kõlvald K, Auerbach A, Ots-Rosenberg M.
    Medicina (Kaunas); 2016 Jun 06; 52(6):340-348. PubMed ID: 27932191
    [Abstract] [Full Text] [Related]

  • 25. Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy.
    Fabiano RCG, de Almeida Araújo S, Bambirra EA, Oliveira EA, Simões E Silva AC, Pinheiro SVB.
    Pediatr Nephrol; 2017 Jul 06; 32(7):1211-1220. PubMed ID: 28233100
    [Abstract] [Full Text] [Related]

  • 26. High Neutrophil-To-Lymphocyte Ratio Is an Independent Risk Factor for End Stage Renal Diseases in IgA Nephropathy.
    Wang S, Dong L, Pei G, Jiang Z, Qin A, Tan J, Tang Y, Qin W.
    Front Immunol; 2021 Jul 06; 12():700224. PubMed ID: 34456912
    [Abstract] [Full Text] [Related]

  • 27. Association between urinary C4d levels and disease progression in IgA nephropathy.
    Dong Y, Wang Z, Guo W, Zhu L, Zhou X, Shi S, Liu L, Lv J, Zhang H.
    Nephrol Dial Transplant; 2024 Jul 31; 39(8):1279-1287. PubMed ID: 38178632
    [Abstract] [Full Text] [Related]

  • 28. [Risk factors affecting the long-term outcome of IgA nephropathy].
    Yang NS, Wu QQ, Du Y, Zhang R, Li YJ, Ye RG, Yu XQ.
    Zhonghua Nei Ke Za Zhi; 2005 Aug 31; 44(8):597-600. PubMed ID: 16194415
    [Abstract] [Full Text] [Related]

  • 29. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments.
    Coppo R, Troyanov S, Bellur S, Cattran D, Cook HT, Feehally J, Roberts IS, Morando L, Camilla R, Tesar V, Lunberg S, Gesualdo L, Emma F, Rollino C, Amore A, Praga M, Feriozzi S, Segoloni G, Pani A, Cancarini G, Durlik M, Moggia E, Mazzucco G, Giannakakis C, Honsova E, Sundelin BB, Di Palma AM, Ferrario F, Gutierrez E, Asunis AM, Barratt J, Tardanico R, Perkowska-Ptasinska A, VALIGA study of the ERA-EDTA Immunonephrology Working Group.
    Kidney Int; 2014 Oct 31; 86(4):828-36. PubMed ID: 24694989
    [Abstract] [Full Text] [Related]

  • 30. Clinical and histological differences between adults and children in new onset IgA nephropathy.
    Cambier A, Rabant M, El Karoui K, Peuchmaur M, Servais A, Hertig A, Deschenes G, Salomon R, Hogan J, Robert T.
    Pediatr Nephrol; 2020 Oct 31; 35(10):1897-1905. PubMed ID: 32444925
    [Abstract] [Full Text] [Related]

  • 31. The prognostic effect of immunosuppressive therapy in IgA nephropathy with stage 3 or 4 chronic kidney disease.
    Yang X, Ma F, Bai M, Wang Y, Jia Q, Dong R, Liu C, Sun S.
    Ren Fail; 2021 Aug 10; 43(1):1180-1187. PubMed ID: 34376108
    [Abstract] [Full Text] [Related]

  • 32. Urine β2-Microglobulin and Retinol-Binding Protein and Renal Disease Progression in IgA Nephropathy.
    Shen X, Cheng J, Yu G, Li X, Li H, Chen J.
    Front Med (Lausanne); 2021 Aug 10; 8():792782. PubMed ID: 35004762
    [Abstract] [Full Text] [Related]

  • 33. Predictive value of sub classification of focal segmental glomerular sclerosis in Oxford classification of IgA nephropathy.
    Yu F, Zhu X, Yuan S, Chen X, Li Z, Qu Z, Liu H, Sun L, Liu F.
    Ann Med; 2021 Dec 10; 53(1):587-595. PubMed ID: 33825605
    [Abstract] [Full Text] [Related]

  • 34. The predictive value of Oxford MEST-C classification to immunosuppressive therapy of IgA nephropathy.
    Rui Y, Yang Z, Zhai Z, Zhao C, Tang L.
    Int Urol Nephrol; 2022 Apr 10; 54(4):959-967. PubMed ID: 34383207
    [Abstract] [Full Text] [Related]

  • 35. High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study.
    Gong WY, Liu M, Luo D, Liu FN, Yin LH, Li YQ, Zhang J, Peng H.
    BMC Nephrol; 2019 Apr 30; 20(1):150. PubMed ID: 31039758
    [Abstract] [Full Text] [Related]

  • 36. Reduction in proteinuria after immunosuppressive therapy and long-term kidney outcomes in patients with immunoglobulin A nephropathy.
    Kang SC, Kim HW, Chang TI, Kang EW, Lim BJ, Park JT, Yoo TH, Jeong HJ, Kang SW, Han SH.
    Korean J Intern Med; 2021 Sep 30; 36(5):1169-1180. PubMed ID: 33561333
    [Abstract] [Full Text] [Related]

  • 37. Roles of mesangial C3 and C1q deposition in the clinical manifestations and prognosis of IgAN.
    Wang S, Dong L, Qin A, Tan J, Zhou X, Qin W.
    Int Immunopharmacol; 2023 Jul 30; 120():110354. PubMed ID: 37235963
    [Abstract] [Full Text] [Related]

  • 38. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
    Kang Z, Li Z, Duan C, Wu T, Xun M, Ding Y, Zhang Y, Zhang L, Yin Y.
    Pediatr Nephrol; 2015 Jul 30; 30(7):1121-9. PubMed ID: 25773534
    [Abstract] [Full Text] [Related]

  • 39. Tubular atrophy/interstitial fibrosis scores of Oxford classification combinded with proteinuria level at biopsy provides earlier risk prediction in lgA nephropathy.
    Zhu X, Li H, Liu Y, You J, Qu Z, Yuan S, Peng Y, Liu F, Liu H.
    Sci Rep; 2017 Apr 24; 7(1):1100. PubMed ID: 28439112
    [Abstract] [Full Text] [Related]

  • 40. Combined Effects of the Serum IgA/C3 Ratio and Glomerular C3 Staining on the Renal Outcome in Adult Immunoglobulin A Nephropathy.
    Yang D, Pei G, Wang S, Qin A, Tang Y, Qin W.
    Kidney Blood Press Res; 2024 Apr 24; 49(1):246-257. PubMed ID: 38382485
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.